Skip to content

Long-term Follow-up of Children Born in the PETN Studies

Langzeiteffekt Einer Pentaerithrityltetranitrat (PETN)-Behandlung in Der Schwangerschaft - Nachbeobachtung Der Kinder Der PETN-Studien

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06534307
Acronym
LOOP
Enrollment
228
Registered
2024-08-02
Start date
2024-06-01
Completion date
2028-03-31
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Growth Restriction, Pentaerithrityl Teratnitrate in Pregnancy, Long-Term Effects to Children

Brief summary

In every 10th pregnancy, the child in the uterus is insufficiently nourished, a so-called growth retardation. This occurs when the child cannot reach its growth potential due to an undersupply in the uterus. This inadequate supply is considered a developmental cause for the later development of physical diseases like cardiovascular diseases, sugar metabolism disorders and obesity as well as mental developmental problems (for example problems in cognitive skills, deficits in language development, concentration and attention). From 2002 to 2008, 111 patients with impaired placental blood flow were included in a small study and treated with Pentalong or placebo. From 2017 to 2022, the positive effects of the study treatment were tested on a larger number of patients. A total of 317 pregnant women were included at 14 participating study centers in Germany. In this follow-up study, the development of the children born in the two studies will be examined. The study consists of two independent parts: firstly, questionnaires are answered by the former participants and secondly, an on-site visit is carried out to check the physical and mental health of the child.

Detailed description

Pregnancies in which impaired uterine blood flow is detected by Doppler measurements during routine examinations in the second trimester are at high risk of developing fetal growth restriction (FGR). FGR affects 10% of pregnancies and is the leading cause of perinatal mortality and morbidity. In addition, intrauterine growth restriction places a lifelong burden on the physical and mental health of affected children. Epidemiological studies have shown that children with FGR have an increased risk of developing type 2 diabetes mellitus, hypertension, dyslipidemia and a high BMI. In addition, the affected children show disorders in hormonal balance and pubertal development as well as specific impairments of various cognitive and neurocognitive functions. There is also a link between FGR and lower cognitive ability in preschool children, school-age children and young adults, as well as lower communication, language and reading skills in school-age children. Neuronal development (e.g. EEG frequency spectra, resting-state networks) and executive functions are also impaired by FGR. In the follow-up study, the children will be examined from the age of 6. Here, the effects of PETN on the development of children of women with high-risk pregnancies can be further investigated and a comparative study of growth-retarded and normal-growth children can also be carried out.

Interventions

BEHAVIORALQuestionnaire Child Behaviour Checklist

The Child Behavior Checklist comprises items assigned to 8 subscales describing various behavioral areas. These subscales can be summed up to scores for internalizing and externalizing problems as well as a total score. Checklist scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean higher amount of problems.

BEHAVIORALQuestionnaire Young Self Report

The Questionnaire Young Self Report comprises items assigned to 8 subscales describing various behavioral areas. These subscales can be summed up to scores for internalizing and externalizing problems as well as a total score.

DIAGNOSTIC_TESTphysical examination

physical development examination including height (in cm), weight (in g) and tanner states

DIAGNOSTIC_TESTmetabolic examination

metabolic development using blood analysis including blood components, metabolic parameters (Glucose, HbA1c, cholestrol)

BEHAVIORALQuestionnaire Reynolds Intellectual Assessment Scales and Screening

The RIAS is standardized intelligence test. The RIAS provides an Total Intelligence Index (GIX, estimate of the general intelligence/g-factor), Verbal Intelligence Index (VIX) and the Nonverbal Intelligence Index (NIX). Test scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean better cognitive performance.

DIAGNOSTIC_TESTelectroencephalogram

neurocognitive development

OTHERQuestionnaire Movement Assessment Battery for Children

The M-ABC-2 is an standardized test to assess the motoric development. Adding up subscores addressing manual dexterity, aiming and catching, and balance delivers a total score of the motoric performance. Test scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean better performance.

OTHERQuestionnaire Continuous Performance Test

The CPT measures selective attention, sustained attention as well as impulsive behavior. Checklist scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean worse performance.

OTHERQuestionnaire Diagnostic System for Mental Disorders

The FBB-ADHS assesses a total score for ADHD-like behavior and subscores for the symptom trias of ADHD (attention deficit, motoric hyperactivity as well as impulsive behavior, Questionnaire scores are reported on a T-scale. Range of T-scale from scores 20 to 100 (average performance between scores 40 and 60). Higher scores mean higher amount of symptoms.

DIAGNOSTIC_TESTkidney function tests

urine examination (proteomics, cytokines, lipidomics)

OTHERQuestionnaire Five to Fifteen

The FTF 5-15R is a questionnaire to evaluate the child's developmental outcome in different areas of everyday life (cognition, language, and motor impairment as well as social, emotional, and behavioral problems). Individual item scores are added up per area and divided by the number of items. This results in a common scale value. Range of Percentile scores from 0 to 100 (0-90: no developmental problem; 90 and higher: hint for developmental problem). Higher scores mean worse developmental outcome.

DIAGNOSTIC_TESTcardiovacular examination

measurement of pulse wave velocity

Sponsors

Jena University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* mothers participation in one of the PETN studies * age above 5 years * completion of questionnaires for self reported data * written consent for physical examination

Exclusion criteria

- only physical examination: * physical and mental states preventing physical examination

Design outcomes

Primary

MeasureTime frameDescription
childrens behaviourup to 2 years after study inclusiontotal score of either CBCL/16-18R or YSR/11-18R

Secondary

MeasureTime frameDescription
physical development weightup to 2 years after study inclusionweight of the child in kg
age appropriate developmentup to 2 years after study inclusionage appropriate development documented as yes or no question in german routine examination plan (Kinderuntersuchungsheft) in the last 6 years at caregivers
cognitive, motoric, and exectuve functionup to 2 years after study inclusionscores of the eight domains of the FTF 5-15-R
physical developmentage above 10 yearsself reported tanner states
cardiovascular developmentage of 6 to 8 yearspulse wave velosity
physical development heightup to 2 years after study inclusionheight of the child in cm
motoric developmentage of 6 to 8 yearstotal score of M-ABC-2
attention behaviourage of 6 to 8 yearsscores of the four domains of the cpt
symptoms of attention and activity disordersage of 6 to 8 yearstotal scores of DISYPS-III
neurocognitive developmentage of 6 to 8 yearsresults of EEG power measurement in alpha band
epigenetic analysisage of 6 to 8 yearsDNA-methylation
IQ developmentage of 6 to 8 yearsscores of RIAS test

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026